180597-85-7

Basic information

• Product Name: 2-BROMO-4-BROMOMETHYL-THIAZOLE
• Synonyms: 2-BROMO-4-BROMOMETHYL-THIAZOLE;2-bromo-4-(bromomethyl)-1,3-thiazole
• CAS NO: 180597-85-7
• Molecular Formula: C₄H₃Br₂NS
• Molecular Weight: 256.95
• Mol File: 180597-85-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-BROMO-4-BROMOMETHYL-THIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-4-BROMOMETHYL-THIAZOLE(180597-85-7)
• EPA Substance Registry System: 2-BROMO-4-BROMOMETHYL-THIAZOLE(180597-85-7)

Safety Data

• Hazardous Substances Data: 180597-85-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-BROMO-4-BROMOMETHYL-THIAZOLE is used as a building block for the synthesis of pharmaceuticals due to its versatile reactivity and ability to participate in various organic reactions.
Used in Agricultural Chemicals Industry:
2-BROMO-4-BROMOMETHYL-THIAZOLE is used as a key intermediate in the production of agricultural chemicals, contributing to the development of effective and innovative agrochemical products.
Used in Organic Chemistry:
2-BROMO-4-BROMOMETHYL-THIAZOLE is utilized as a valuable intermediate in the manufacturing of a wide range of complex organic compounds, showcasing its importance in the field of organic chemistry.

Upstream product

• 5198-86-7 (2-bromo-1,3-thiazol-4-yl)methanol 
• 59608-97-8 4-(chloromethyl)thiazol-2-amine hydrochloride 

Downstream Products

• 1446194-11-1 (2Z)-{[(2-bromo-1,3-thiazol-4-yl)methoxy]imino}(phenyl)acetonitrile 
• 1187835-17-1 N-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1-(5-methyl-1H-tetrazol-1-yl)-1-phenylmethanimine 
• 1187836-85-6 3-[{[(2-bromo-1,3-thiazol-4-yl)methoxy]imino}(1-methyl-1H-tetrazol-5-yl)methyl]-N,N-dimethylaniline 
• 1187836-73-2 N-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1-[3-(methylsulfanyl)phenyl]-1-(1-methyl-1H-tetrazol-5-yl)methanimine 
• 1187834-03-2 N-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1-(1-methyl-1H-tetrazol-5-yl)-1-phenyl-methanimine 

Relevant articles and documents

Benzofuran derivative as well as preparation method and medical application thereof

The invention relates to benzofuran derivatives, and a preparation method and medical application thereof. Specifically, the present invention relates to a new benzofuran derivative represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, and application of the composition as a therapeutic agent, especially as a PAR-4 antagonist, wherein each substituent of general formula (I) is as defined in the specification.

HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I) : wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis treatment of narcolepsy.

Oxazolidinone compounds and its use in medicine

The invention relates to an oxazolidinone compound and an application thereof to preparation of drugs for preventing and treating thromboembolic diseases and in particular relates to a compound shown in a general formula (I) in the specification or stereoisomers, geometrical isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound. All the variables are defined in the specification. The invention also relates to an application of the compound shown in the general formula (I) or the stereoisomers, geometrical isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as drugs and in particular relates to an application of the substances as drugs for preventing and treating thromboembolic diseases.

Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides

The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently available to treat these neglected diseases leave much to be

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.